nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A7—Methotrexate—bone cancer	0.263	0.491	CbGbCtD
Ganciclovir—SLC22A8—Methotrexate—bone cancer	0.161	0.3	CbGbCtD
Ganciclovir—SLC22A6—Methotrexate—bone cancer	0.112	0.209	CbGbCtD
Ganciclovir—Haemoglobin—Methotrexate—bone cancer	0.000439	0.000946	CcSEcCtD
Ganciclovir—Haemorrhage—Methotrexate—bone cancer	0.000437	0.000941	CcSEcCtD
Ganciclovir—Hepatitis—Methotrexate—bone cancer	0.000437	0.000941	CcSEcCtD
Ganciclovir—Sweating—Epirubicin—bone cancer	0.000436	0.000941	CcSEcCtD
Ganciclovir—Pollakiuria—Doxorubicin—bone cancer	0.000436	0.000941	CcSEcCtD
Ganciclovir—Haematuria—Epirubicin—bone cancer	0.000434	0.000936	CcSEcCtD
Ganciclovir—Pharyngitis—Methotrexate—bone cancer	0.000433	0.000934	CcSEcCtD
Ganciclovir—Urinary tract disorder—Methotrexate—bone cancer	0.000431	0.00093	CcSEcCtD
Ganciclovir—Photosensitivity reaction—Doxorubicin—bone cancer	0.000431	0.00093	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Epirubicin—bone cancer	0.000431	0.000928	CcSEcCtD
Ganciclovir—Urethral disorder—Methotrexate—bone cancer	0.000428	0.000923	CcSEcCtD
Ganciclovir—Weight decreased—Doxorubicin—bone cancer	0.000427	0.000921	CcSEcCtD
Ganciclovir—Hyperglycaemia—Doxorubicin—bone cancer	0.000426	0.000919	CcSEcCtD
Ganciclovir—Agranulocytosis—Epirubicin—bone cancer	0.000425	0.000916	CcSEcCtD
Ganciclovir—Pneumonia—Doxorubicin—bone cancer	0.000424	0.000913	CcSEcCtD
Ganciclovir—Infestation—Doxorubicin—bone cancer	0.000421	0.000908	CcSEcCtD
Ganciclovir—Infestation NOS—Doxorubicin—bone cancer	0.000421	0.000908	CcSEcCtD
Ganciclovir—Visual impairment—Methotrexate—bone cancer	0.000421	0.000907	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000418	0.0009	CcSEcCtD
Ganciclovir—Hypersensitivity—Cisplatin—bone cancer	0.000417	0.000898	CcSEcCtD
Ganciclovir—Renal failure—Doxorubicin—bone cancer	0.000414	0.000893	CcSEcCtD
Ganciclovir—Erythema multiforme—Methotrexate—bone cancer	0.000413	0.00089	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Doxorubicin—bone cancer	0.000413	0.00089	CcSEcCtD
Ganciclovir—Haemoglobin—Epirubicin—bone cancer	0.000411	0.000885	CcSEcCtD
Ganciclovir—Stomatitis—Doxorubicin—bone cancer	0.000411	0.000885	CcSEcCtD
Ganciclovir—Jaundice—Doxorubicin—bone cancer	0.000411	0.000885	CcSEcCtD
Ganciclovir—Rhinitis—Epirubicin—bone cancer	0.00041	0.000883	CcSEcCtD
Ganciclovir—Conjunctivitis—Doxorubicin—bone cancer	0.000409	0.000883	CcSEcCtD
Ganciclovir—Urinary tract infection—Doxorubicin—bone cancer	0.000409	0.000883	CcSEcCtD
Ganciclovir—Haemorrhage—Epirubicin—bone cancer	0.000409	0.000881	CcSEcCtD
Ganciclovir—Hepatitis—Epirubicin—bone cancer	0.000409	0.000881	CcSEcCtD
Ganciclovir—Tinnitus—Methotrexate—bone cancer	0.000407	0.000878	CcSEcCtD
Ganciclovir—Hypoaesthesia—Epirubicin—bone cancer	0.000407	0.000876	CcSEcCtD
Ganciclovir—Asthenia—Cisplatin—bone cancer	0.000406	0.000874	CcSEcCtD
Ganciclovir—Pharyngitis—Epirubicin—bone cancer	0.000406	0.000874	CcSEcCtD
Ganciclovir—Sweating—Doxorubicin—bone cancer	0.000404	0.00087	CcSEcCtD
Ganciclovir—Urinary tract disorder—Epirubicin—bone cancer	0.000404	0.00087	CcSEcCtD
Ganciclovir—Oedema peripheral—Epirubicin—bone cancer	0.000403	0.000868	CcSEcCtD
Ganciclovir—Haematuria—Doxorubicin—bone cancer	0.000402	0.000866	CcSEcCtD
Ganciclovir—Connective tissue disorder—Epirubicin—bone cancer	0.000402	0.000866	CcSEcCtD
Ganciclovir—Urethral disorder—Epirubicin—bone cancer	0.000401	0.000864	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Doxorubicin—bone cancer	0.000398	0.000859	CcSEcCtD
Ganciclovir—Angiopathy—Methotrexate—bone cancer	0.000396	0.000854	CcSEcCtD
Ganciclovir—Visual impairment—Epirubicin—bone cancer	0.000394	0.000849	CcSEcCtD
Ganciclovir—Mediastinal disorder—Methotrexate—bone cancer	0.000394	0.000848	CcSEcCtD
Ganciclovir—Agranulocytosis—Doxorubicin—bone cancer	0.000393	0.000847	CcSEcCtD
Ganciclovir—Chills—Methotrexate—bone cancer	0.000392	0.000845	CcSEcCtD
Ganciclovir—Diarrhoea—Cisplatin—bone cancer	0.000387	0.000834	CcSEcCtD
Ganciclovir—Erythema multiforme—Epirubicin—bone cancer	0.000386	0.000833	CcSEcCtD
Ganciclovir—Alopecia—Methotrexate—bone cancer	0.000386	0.000832	CcSEcCtD
Ganciclovir—Mental disorder—Methotrexate—bone cancer	0.000383	0.000825	CcSEcCtD
Ganciclovir—Tinnitus—Epirubicin—bone cancer	0.000381	0.000821	CcSEcCtD
Ganciclovir—Malnutrition—Methotrexate—bone cancer	0.00038	0.000819	CcSEcCtD
Ganciclovir—Haemoglobin—Doxorubicin—bone cancer	0.00038	0.000819	CcSEcCtD
Ganciclovir—Rhinitis—Doxorubicin—bone cancer	0.000379	0.000817	CcSEcCtD
Ganciclovir—Hepatitis—Doxorubicin—bone cancer	0.000378	0.000815	CcSEcCtD
Ganciclovir—Haemorrhage—Doxorubicin—bone cancer	0.000378	0.000815	CcSEcCtD
Ganciclovir—Hypoaesthesia—Doxorubicin—bone cancer	0.000376	0.000811	CcSEcCtD
Ganciclovir—Pharyngitis—Doxorubicin—bone cancer	0.000375	0.000809	CcSEcCtD
Ganciclovir—Urinary tract disorder—Doxorubicin—bone cancer	0.000373	0.000805	CcSEcCtD
Ganciclovir—Oedema peripheral—Doxorubicin—bone cancer	0.000372	0.000803	CcSEcCtD
Ganciclovir—Dysgeusia—Methotrexate—bone cancer	0.000372	0.000802	CcSEcCtD
Ganciclovir—Connective tissue disorder—Doxorubicin—bone cancer	0.000372	0.000801	CcSEcCtD
Ganciclovir—Angiopathy—Epirubicin—bone cancer	0.000371	0.000799	CcSEcCtD
Ganciclovir—Urethral disorder—Doxorubicin—bone cancer	0.000371	0.000799	CcSEcCtD
Ganciclovir—Mediastinal disorder—Epirubicin—bone cancer	0.000368	0.000794	CcSEcCtD
Ganciclovir—Back pain—Methotrexate—bone cancer	0.000368	0.000793	CcSEcCtD
Ganciclovir—Chills—Epirubicin—bone cancer	0.000367	0.00079	CcSEcCtD
Ganciclovir—Arrhythmia—Epirubicin—bone cancer	0.000365	0.000787	CcSEcCtD
Ganciclovir—Visual impairment—Doxorubicin—bone cancer	0.000364	0.000785	CcSEcCtD
Ganciclovir—Alopecia—Epirubicin—bone cancer	0.000361	0.000778	CcSEcCtD
Ganciclovir—Vomiting—Cisplatin—bone cancer	0.000359	0.000775	CcSEcCtD
Ganciclovir—Vision blurred—Methotrexate—bone cancer	0.000358	0.000772	CcSEcCtD
Ganciclovir—Mental disorder—Epirubicin—bone cancer	0.000358	0.000772	CcSEcCtD
Ganciclovir—Erythema multiforme—Doxorubicin—bone cancer	0.000357	0.000771	CcSEcCtD
Ganciclovir—Rash—Cisplatin—bone cancer	0.000356	0.000768	CcSEcCtD
Ganciclovir—Dermatitis—Cisplatin—bone cancer	0.000356	0.000768	CcSEcCtD
Ganciclovir—Malnutrition—Epirubicin—bone cancer	0.000356	0.000767	CcSEcCtD
Ganciclovir—Ill-defined disorder—Methotrexate—bone cancer	0.000353	0.00076	CcSEcCtD
Ganciclovir—Tinnitus—Doxorubicin—bone cancer	0.000353	0.00076	CcSEcCtD
Ganciclovir—Anaemia—Methotrexate—bone cancer	0.000351	0.000757	CcSEcCtD
Ganciclovir—Flatulence—Epirubicin—bone cancer	0.000351	0.000756	CcSEcCtD
Ganciclovir—Tension—Epirubicin—bone cancer	0.000349	0.000753	CcSEcCtD
Ganciclovir—Dysgeusia—Epirubicin—bone cancer	0.000348	0.000751	CcSEcCtD
Ganciclovir—Nervousness—Epirubicin—bone cancer	0.000345	0.000745	CcSEcCtD
Ganciclovir—Back pain—Epirubicin—bone cancer	0.000344	0.000742	CcSEcCtD
Ganciclovir—Angiopathy—Doxorubicin—bone cancer	0.000343	0.00074	CcSEcCtD
Ganciclovir—Malaise—Methotrexate—bone cancer	0.000343	0.000739	CcSEcCtD
Ganciclovir—Muscle spasms—Epirubicin—bone cancer	0.000342	0.000737	CcSEcCtD
Ganciclovir—Vertigo—Methotrexate—bone cancer	0.000342	0.000736	CcSEcCtD
Ganciclovir—Mediastinal disorder—Doxorubicin—bone cancer	0.000341	0.000735	CcSEcCtD
Ganciclovir—Leukopenia—Methotrexate—bone cancer	0.00034	0.000733	CcSEcCtD
Ganciclovir—Chills—Doxorubicin—bone cancer	0.000339	0.000731	CcSEcCtD
Ganciclovir—Arrhythmia—Doxorubicin—bone cancer	0.000338	0.000728	CcSEcCtD
Ganciclovir—Nausea—Cisplatin—bone cancer	0.000336	0.000724	CcSEcCtD
Ganciclovir—Vision blurred—Epirubicin—bone cancer	0.000335	0.000723	CcSEcCtD
Ganciclovir—Alopecia—Doxorubicin—bone cancer	0.000334	0.00072	CcSEcCtD
Ganciclovir—Cough—Methotrexate—bone cancer	0.000332	0.000715	CcSEcCtD
Ganciclovir—Mental disorder—Doxorubicin—bone cancer	0.000331	0.000714	CcSEcCtD
Ganciclovir—Ill-defined disorder—Epirubicin—bone cancer	0.00033	0.000712	CcSEcCtD
Ganciclovir—Convulsion—Methotrexate—bone cancer	0.000329	0.00071	CcSEcCtD
Ganciclovir—Malnutrition—Doxorubicin—bone cancer	0.000329	0.00071	CcSEcCtD
Ganciclovir—Anaemia—Epirubicin—bone cancer	0.000329	0.000709	CcSEcCtD
Ganciclovir—Agitation—Epirubicin—bone cancer	0.000327	0.000705	CcSEcCtD
Ganciclovir—Flatulence—Doxorubicin—bone cancer	0.000324	0.000699	CcSEcCtD
Ganciclovir—Chest pain—Methotrexate—bone cancer	0.000324	0.000698	CcSEcCtD
Ganciclovir—Arthralgia—Methotrexate—bone cancer	0.000324	0.000698	CcSEcCtD
Ganciclovir—Myalgia—Methotrexate—bone cancer	0.000324	0.000698	CcSEcCtD
Ganciclovir—Tension—Doxorubicin—bone cancer	0.000323	0.000696	CcSEcCtD
Ganciclovir—Dysgeusia—Doxorubicin—bone cancer	0.000322	0.000695	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000321	0.000693	CcSEcCtD
Ganciclovir—Malaise—Epirubicin—bone cancer	0.000321	0.000692	CcSEcCtD
Ganciclovir—Discomfort—Methotrexate—bone cancer	0.00032	0.000689	CcSEcCtD
Ganciclovir—Nervousness—Doxorubicin—bone cancer	0.00032	0.000689	CcSEcCtD
Ganciclovir—Vertigo—Epirubicin—bone cancer	0.00032	0.000689	CcSEcCtD
Ganciclovir—Leukopenia—Epirubicin—bone cancer	0.000318	0.000686	CcSEcCtD
Ganciclovir—Back pain—Doxorubicin—bone cancer	0.000318	0.000686	CcSEcCtD
Ganciclovir—Muscle spasms—Doxorubicin—bone cancer	0.000316	0.000682	CcSEcCtD
Ganciclovir—Confusional state—Methotrexate—bone cancer	0.000313	0.000674	CcSEcCtD
Ganciclovir—Cough—Epirubicin—bone cancer	0.00031	0.000669	CcSEcCtD
Ganciclovir—Anaphylactic shock—Methotrexate—bone cancer	0.00031	0.000669	CcSEcCtD
Ganciclovir—Vision blurred—Doxorubicin—bone cancer	0.00031	0.000669	CcSEcCtD
Ganciclovir—Convulsion—Epirubicin—bone cancer	0.000308	0.000664	CcSEcCtD
Ganciclovir—Infection—Methotrexate—bone cancer	0.000308	0.000664	CcSEcCtD
Ganciclovir—Hypertension—Epirubicin—bone cancer	0.000307	0.000662	CcSEcCtD
Ganciclovir—Ill-defined disorder—Doxorubicin—bone cancer	0.000305	0.000658	CcSEcCtD
Ganciclovir—Anaemia—Doxorubicin—bone cancer	0.000304	0.000656	CcSEcCtD
Ganciclovir—Thrombocytopenia—Methotrexate—bone cancer	0.000304	0.000655	CcSEcCtD
Ganciclovir—Chest pain—Epirubicin—bone cancer	0.000303	0.000653	CcSEcCtD
Ganciclovir—Arthralgia—Epirubicin—bone cancer	0.000303	0.000653	CcSEcCtD
Ganciclovir—Myalgia—Epirubicin—bone cancer	0.000303	0.000653	CcSEcCtD
Ganciclovir—Agitation—Doxorubicin—bone cancer	0.000302	0.000652	CcSEcCtD
Ganciclovir—Anxiety—Epirubicin—bone cancer	0.000302	0.000651	CcSEcCtD
Ganciclovir—Skin disorder—Methotrexate—bone cancer	0.000301	0.00065	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000301	0.000648	CcSEcCtD
Ganciclovir—Hyperhidrosis—Methotrexate—bone cancer	0.0003	0.000647	CcSEcCtD
Ganciclovir—Discomfort—Epirubicin—bone cancer	0.000299	0.000645	CcSEcCtD
Ganciclovir—Malaise—Doxorubicin—bone cancer	0.000297	0.00064	CcSEcCtD
Ganciclovir—Dry mouth—Epirubicin—bone cancer	0.000296	0.000638	CcSEcCtD
Ganciclovir—Vertigo—Doxorubicin—bone cancer	0.000296	0.000637	CcSEcCtD
Ganciclovir—Anorexia—Methotrexate—bone cancer	0.000296	0.000637	CcSEcCtD
Ganciclovir—Leukopenia—Doxorubicin—bone cancer	0.000295	0.000635	CcSEcCtD
Ganciclovir—Confusional state—Epirubicin—bone cancer	0.000293	0.000631	CcSEcCtD
Ganciclovir—Oedema—Epirubicin—bone cancer	0.00029	0.000626	CcSEcCtD
Ganciclovir—Anaphylactic shock—Epirubicin—bone cancer	0.00029	0.000626	CcSEcCtD
Ganciclovir—Hypotension—Methotrexate—bone cancer	0.00029	0.000625	CcSEcCtD
Ganciclovir—Infection—Epirubicin—bone cancer	0.000288	0.000622	CcSEcCtD
Ganciclovir—Cough—Doxorubicin—bone cancer	0.000287	0.000619	CcSEcCtD
Ganciclovir—Convulsion—Doxorubicin—bone cancer	0.000285	0.000615	CcSEcCtD
Ganciclovir—Thrombocytopenia—Epirubicin—bone cancer	0.000284	0.000613	CcSEcCtD
Ganciclovir—Hypertension—Doxorubicin—bone cancer	0.000284	0.000613	CcSEcCtD
Ganciclovir—Tachycardia—Epirubicin—bone cancer	0.000283	0.000611	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000283	0.000609	CcSEcCtD
Ganciclovir—Skin disorder—Epirubicin—bone cancer	0.000282	0.000608	CcSEcCtD
Ganciclovir—Hyperhidrosis—Epirubicin—bone cancer	0.000281	0.000605	CcSEcCtD
Ganciclovir—Insomnia—Methotrexate—bone cancer	0.000281	0.000605	CcSEcCtD
Ganciclovir—Chest pain—Doxorubicin—bone cancer	0.00028	0.000604	CcSEcCtD
Ganciclovir—Arthralgia—Doxorubicin—bone cancer	0.00028	0.000604	CcSEcCtD
Ganciclovir—Myalgia—Doxorubicin—bone cancer	0.00028	0.000604	CcSEcCtD
Ganciclovir—Anxiety—Doxorubicin—bone cancer	0.000279	0.000602	CcSEcCtD
Ganciclovir—Paraesthesia—Methotrexate—bone cancer	0.000279	0.000601	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000278	0.0006	CcSEcCtD
Ganciclovir—Discomfort—Doxorubicin—bone cancer	0.000277	0.000597	CcSEcCtD
Ganciclovir—Anorexia—Epirubicin—bone cancer	0.000277	0.000597	CcSEcCtD
Ganciclovir—Dyspnoea—Methotrexate—bone cancer	0.000277	0.000596	CcSEcCtD
Ganciclovir—Somnolence—Methotrexate—bone cancer	0.000276	0.000595	CcSEcCtD
Ganciclovir—Dry mouth—Doxorubicin—bone cancer	0.000274	0.000591	CcSEcCtD
Ganciclovir—Dyspepsia—Methotrexate—bone cancer	0.000273	0.000589	CcSEcCtD
Ganciclovir—Hypotension—Epirubicin—bone cancer	0.000271	0.000585	CcSEcCtD
Ganciclovir—Confusional state—Doxorubicin—bone cancer	0.000271	0.000584	CcSEcCtD
Ganciclovir—Decreased appetite—Methotrexate—bone cancer	0.00027	0.000581	CcSEcCtD
Ganciclovir—Oedema—Doxorubicin—bone cancer	0.000269	0.000579	CcSEcCtD
Ganciclovir—Anaphylactic shock—Doxorubicin—bone cancer	0.000269	0.000579	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Methotrexate—bone cancer	0.000268	0.000577	CcSEcCtD
Ganciclovir—Fatigue—Methotrexate—bone cancer	0.000267	0.000577	CcSEcCtD
Ganciclovir—Infection—Doxorubicin—bone cancer	0.000267	0.000575	CcSEcCtD
Ganciclovir—Pain—Methotrexate—bone cancer	0.000265	0.000572	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000265	0.00057	CcSEcCtD
Ganciclovir—Thrombocytopenia—Doxorubicin—bone cancer	0.000263	0.000567	CcSEcCtD
Ganciclovir—Insomnia—Epirubicin—bone cancer	0.000263	0.000566	CcSEcCtD
Ganciclovir—Tachycardia—Doxorubicin—bone cancer	0.000262	0.000565	CcSEcCtD
Ganciclovir—Skin disorder—Doxorubicin—bone cancer	0.000261	0.000562	CcSEcCtD
Ganciclovir—Paraesthesia—Epirubicin—bone cancer	0.000261	0.000562	CcSEcCtD
Ganciclovir—Hyperhidrosis—Doxorubicin—bone cancer	0.00026	0.00056	CcSEcCtD
Ganciclovir—Dyspnoea—Epirubicin—bone cancer	0.000259	0.000558	CcSEcCtD
Ganciclovir—Somnolence—Epirubicin—bone cancer	0.000258	0.000556	CcSEcCtD
Ganciclovir—Anorexia—Doxorubicin—bone cancer	0.000256	0.000552	CcSEcCtD
Ganciclovir—Feeling abnormal—Methotrexate—bone cancer	0.000256	0.000551	CcSEcCtD
Ganciclovir—Dyspepsia—Epirubicin—bone cancer	0.000256	0.000551	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Methotrexate—bone cancer	0.000254	0.000547	CcSEcCtD
Ganciclovir—Decreased appetite—Epirubicin—bone cancer	0.000252	0.000544	CcSEcCtD
Ganciclovir—Hypotension—Doxorubicin—bone cancer	0.000251	0.000541	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Epirubicin—bone cancer	0.000251	0.00054	CcSEcCtD
Ganciclovir—Fatigue—Epirubicin—bone cancer	0.00025	0.00054	CcSEcCtD
Ganciclovir—Constipation—Epirubicin—bone cancer	0.000248	0.000535	CcSEcCtD
Ganciclovir—Pain—Epirubicin—bone cancer	0.000248	0.000535	CcSEcCtD
Ganciclovir—Urticaria—Methotrexate—bone cancer	0.000246	0.000531	CcSEcCtD
Ganciclovir—Abdominal pain—Methotrexate—bone cancer	0.000245	0.000529	CcSEcCtD
Ganciclovir—Body temperature increased—Methotrexate—bone cancer	0.000245	0.000529	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000245	0.000528	CcSEcCtD
Ganciclovir—Insomnia—Doxorubicin—bone cancer	0.000243	0.000524	CcSEcCtD
Ganciclovir—Paraesthesia—Doxorubicin—bone cancer	0.000241	0.00052	CcSEcCtD
Ganciclovir—Dyspnoea—Doxorubicin—bone cancer	0.000239	0.000516	CcSEcCtD
Ganciclovir—Feeling abnormal—Epirubicin—bone cancer	0.000239	0.000516	CcSEcCtD
Ganciclovir—Somnolence—Doxorubicin—bone cancer	0.000239	0.000515	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Epirubicin—bone cancer	0.000237	0.000512	CcSEcCtD
Ganciclovir—Dyspepsia—Doxorubicin—bone cancer	0.000236	0.00051	CcSEcCtD
Ganciclovir—Decreased appetite—Doxorubicin—bone cancer	0.000234	0.000503	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000232	0.0005	CcSEcCtD
Ganciclovir—Fatigue—Doxorubicin—bone cancer	0.000232	0.000499	CcSEcCtD
Ganciclovir—Urticaria—Epirubicin—bone cancer	0.000231	0.000497	CcSEcCtD
Ganciclovir—Pain—Doxorubicin—bone cancer	0.00023	0.000495	CcSEcCtD
Ganciclovir—Constipation—Doxorubicin—bone cancer	0.00023	0.000495	CcSEcCtD
Ganciclovir—Abdominal pain—Epirubicin—bone cancer	0.00023	0.000495	CcSEcCtD
Ganciclovir—Body temperature increased—Epirubicin—bone cancer	0.00023	0.000495	CcSEcCtD
Ganciclovir—Hypersensitivity—Methotrexate—bone cancer	0.000229	0.000493	CcSEcCtD
Ganciclovir—Asthenia—Methotrexate—bone cancer	0.000223	0.00048	CcSEcCtD
Ganciclovir—Feeling abnormal—Doxorubicin—bone cancer	0.000221	0.000477	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Doxorubicin—bone cancer	0.00022	0.000474	CcSEcCtD
Ganciclovir—Pruritus—Methotrexate—bone cancer	0.000219	0.000473	CcSEcCtD
Ganciclovir—Hypersensitivity—Epirubicin—bone cancer	0.000214	0.000461	CcSEcCtD
Ganciclovir—Urticaria—Doxorubicin—bone cancer	0.000213	0.00046	CcSEcCtD
Ganciclovir—Abdominal pain—Doxorubicin—bone cancer	0.000212	0.000458	CcSEcCtD
Ganciclovir—Body temperature increased—Doxorubicin—bone cancer	0.000212	0.000458	CcSEcCtD
Ganciclovir—Diarrhoea—Methotrexate—bone cancer	0.000212	0.000458	CcSEcCtD
Ganciclovir—Asthenia—Epirubicin—bone cancer	0.000208	0.000449	CcSEcCtD
Ganciclovir—Pruritus—Epirubicin—bone cancer	0.000205	0.000443	CcSEcCtD
Ganciclovir—Dizziness—Methotrexate—bone cancer	0.000205	0.000442	CcSEcCtD
Ganciclovir—Diarrhoea—Epirubicin—bone cancer	0.000199	0.000428	CcSEcCtD
Ganciclovir—Hypersensitivity—Doxorubicin—bone cancer	0.000198	0.000427	CcSEcCtD
Ganciclovir—Vomiting—Methotrexate—bone cancer	0.000197	0.000425	CcSEcCtD
Ganciclovir—Rash—Methotrexate—bone cancer	0.000196	0.000422	CcSEcCtD
Ganciclovir—Dermatitis—Methotrexate—bone cancer	0.000195	0.000421	CcSEcCtD
Ganciclovir—Headache—Methotrexate—bone cancer	0.000194	0.000419	CcSEcCtD
Ganciclovir—Asthenia—Doxorubicin—bone cancer	0.000193	0.000415	CcSEcCtD
Ganciclovir—Dizziness—Epirubicin—bone cancer	0.000192	0.000414	CcSEcCtD
Ganciclovir—Pruritus—Doxorubicin—bone cancer	0.00019	0.00041	CcSEcCtD
Ganciclovir—Vomiting—Epirubicin—bone cancer	0.000185	0.000398	CcSEcCtD
Ganciclovir—Nausea—Methotrexate—bone cancer	0.000184	0.000397	CcSEcCtD
Ganciclovir—Diarrhoea—Doxorubicin—bone cancer	0.000184	0.000396	CcSEcCtD
Ganciclovir—Rash—Epirubicin—bone cancer	0.000183	0.000395	CcSEcCtD
Ganciclovir—Dermatitis—Epirubicin—bone cancer	0.000183	0.000394	CcSEcCtD
Ganciclovir—Headache—Epirubicin—bone cancer	0.000182	0.000392	CcSEcCtD
Ganciclovir—Dizziness—Doxorubicin—bone cancer	0.000178	0.000383	CcSEcCtD
Ganciclovir—Nausea—Epirubicin—bone cancer	0.000172	0.000372	CcSEcCtD
Ganciclovir—Vomiting—Doxorubicin—bone cancer	0.000171	0.000368	CcSEcCtD
Ganciclovir—Rash—Doxorubicin—bone cancer	0.000169	0.000365	CcSEcCtD
Ganciclovir—Dermatitis—Doxorubicin—bone cancer	0.000169	0.000365	CcSEcCtD
Ganciclovir—Headache—Doxorubicin—bone cancer	0.000168	0.000363	CcSEcCtD
Ganciclovir—Nausea—Doxorubicin—bone cancer	0.00016	0.000344	CcSEcCtD
